Symptomatic Femoroacetabular Impingement
Conditions
Brief summary
This is a single-group, prospective, intervention study. A total of 30 participants with unilateral symptomatic femoroacetabular impingement will be included into the study. The intervention consists in neuromuscular training for the lower limb muscles (12 weeks, 2 times/week supervised training, 2 times/week home training). The training includes physical exercises routinely used worldwide in clinical settings. No control intervention group was included into the study because nowadays there is no standard conservative treatment for patients with symptomatic femoroacetabular impingement. Assessments will be performed at (1) baseline, (2) mid-intervention, (3) end-intervention, and (4) follow-up. Clinical, functional, neuromuscular and self-reported parameters will be collected during assessments.
Interventions
OTHERNeuromuscular training
Neuromuscular training for the hip and lower limb muscles.The training program is divided into 3 phases, and includes specific exercises for improving the hip range of motion, muscle strength of the hip and lower limb muscles, as well as the trunk stability and coordination. The intervention lasts 12 weeks. Patients will train 2 times/week with a physical therapist and 2 times/weeks alone at home.
Sponsors
Schulthess Klinik
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of unilateral symptomatic FAI according to clinical, radiographic and magnetic resonance imaging criteria * Living place: Canton of Zurich or neighbouring Cantons * Signed written informed consent to participate into the study
Exclusion criteria
* Previous hip surgery * Any surgery to the lower limbs in the prior 6 months * Congenital/developmental dysplasia * Hip osteoarthritis * Initiation of opioid analgesia and corticosteroid injection for hip pain within the prior 30 days * BMI \>35 kg/m2 * Significant cardiorespiratory diseases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hip Function as measured using the Hip Outcome Score questionnaire | Change from Baseline in Hip Function at 12 weeks | Hip Function was assessed using the Hip Outcome Score. The Hip Outcome score is a questionnaire used to evaluate hip function during daily and sport activities. Two independent scores are obtained: one for activities of daily living and one for sport activities. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hip Muscle Strength as measured using dynamometry | Change from Baseline in Hip Muscle Strength at 12 weeks | Hip abduction, adduction, internal rotation and external rotation isometric maximal voluntary contraction strength is evaluated with hand-held dynamometry. Hip flexion and extension isometric maximal voluntary contraction strength is evaluated with isokinetic dynamometry. |
| Movement Control Quality as measured using a visual rating scale | Change from Baseline in Movement Control Quality at 12 weeks | Overall body movement pattern quality is visually assessed during the performance of 5 lower extremity functional tests (single-leg squat, lunge, hop lunge, single-leg bridge, single-leg ventral plank). |
Countries
Switzerland
Outcome results
None listed